Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04014205 |
|---|---|
| Brief Title: | A Study of Tyrosine Kinase Inhibitor ICP-022 in Patients With r/r B-Cell Malignancies |
| First Submitted : | June 18, 2019 |
| First Submitted that Met QC Criteria : | July 9, 2019 |
| First Posted : | July 10, 2019 |
| Last Update Submitted that Met QC Criteria : | December 22, 2020 |
| Last Update Posted : | December 23, 2020 |